ArticleClinical and experimental immunology2020

Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.

A Uzawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.